Clinical trial
How Long Should we Give Steroids for Patients With Severe PCP (HOW LONG)
NCT07328984 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- How Long Should we Give Steroids for Patients With Severe PCP (HOW LONG)
- Lead sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- January 30, 2026
- Completion date
- June 30, 2029
- Enrollment
- 416 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pneumocystis, pneumocystis carinii; infection, resulting from hiv disease, pneumocystis jiroveci pneumonia, pneumocystis jirovecii infection, pneumocystis pneumonia, pneumocystosis associated with aids, pneumocystosis; pneumonia (etiology)